Try our Advanced Search for more refined results
Health - November, 2010
202 articles
- Doctor Indicted Over False Fen-Phen Injury Claims
- Quest, Lab Techs Settle FLSA Suit For $2M
- Justices Wrangle With Standard In Cigna Pension Case
- Novartis Wins OK On $175M Deal To End Bias Action
- 3rd Circ. Revives Suit Against UPMC, Highmark
- AIDS Nonprofit Says BMS Overcharged For Drugs
- J&J Units Target Impax Over Generic Concerta
- AMAG Updates Feraheme Label To Include Safety Risks
- Allergan, AMD, Bosch Face False Marking Suits
- The FTC's Aggression Affirmed
- Alzheimer's Group Hits UPenn, Avid With Patent Suit
- J&J Must Pay Basilea $130M Over License: Dutch Court
- Cardinal Health Buys Chinese Drug Importer For $470M
- New EU Rule Eases Biosimilar Development
- Syntrix Slaps Illumina With Biotech Patent Suit
- Coventry Wins Partial Toss Of Copay Class Action
- Federal Circ. Fleshes Out Prosecution Laches
- Nev. High Court Affirms $58M Award Against Wyeth
- 10 Tips For Avoiding GINA Violations
- Novartis Hit With $1M Ruling In Aredia, Zometa Suit
- NZ Air Ambulance Cos. Settle Price-Fixing Claims
- J&J Recalls 9M Tylenol Meds Over Missing Alcohol Label
- Judge Delays Recusal Ruling For Siegelman, Scrushy
- FDA Crime Head To Depart Amid Misconduct Claims
- Sonova Recalls Cochlear Implants Made By US Unit
- Genzyme, Daiichi Sankyo Fight More Welchol ANDAs
- Judge Won't Rehear Dismissal Bid In Wyeth Pristiq Suit
- McKesson Wins $44M In Iranian Dairy Stake Suit
- 7th Circ. Pins Down Atty Fee Awards In Lanham Case
- J&J Pulls Children's Benadryl, Motrin Off Shelves
- Philly Judge Nixes GSK Paxil Birth Defect Suit
- Pharma Struggles To Escape FCPA Net
- Ohio Group's Health-Law Suit Survives Dismissal Bid
- Implant Maker Seeks To Subpoena Dickstein In IP Spat
- Wyeth Appeals Retaliation Trial Order To High Court
- P&G Asks To Fight Align Suit On Home Turf
- The Content Marketing Revolution
- Senate Commerce Chief Decries Mini-Med Exemption
- Amgen Loses Bid To Wrap Up Teva Patent Fight
- FCA Settlements Top $3B In FY2010
- Chubb Off Hook For IP Suit Over Nutrition Co. Ad
- Bracing For Cigna V. Amara
- Life Tech Sues GenMark Over DNA Test Patent
- HHS Releases Medical-Loss Ratio Regulation
- Avandia Plaintiffs Must Comply With Lone Pine Order: Judge
- Merck Picks Up Another Win In Fosamax Bellwether
- Darvon Maker Pulls Painkiller From US Market
- W.Va. High Court Nixes $4.5M Verdict Against J&J Unit
- Bristol-Myers Hit With False Marking Suit Over 3 Drugs
- CIBC Continues To Dog Attys In Chem Rx Ch. 11
- Sens. Pitch Plan To Let States Opt Out Of Health Reform
- Merck Unit Sues TriGen Over Folic Acid Patents
- Medicare Fraudster Gets 5 Years, $7.9M Restitution
- Class Attys Score $38M Fee In Novartis Sex Bias Suit
- The 21st-Century Law Firm
- EU Drug Agency OKs Rule On Biosimilar Antibodies
- Vioxx Plaintiffs Take $5B Deal Woes To High Court
- King Investors Fail To Speed Suit Over $3.6B Pfizer Sale
- Jones Day Lures Biotech IP Partners From McDermott
- Calif. Nurses Lose Wage Class Action Appeal
- Attorney Suspended Over Conduct In Black Lung Case
- Bristol-Myers Sales Rep Sues For Overtime Pay
- Ropes Gray Reps Genzyme In $265M Diagnostics Sale
- France Says Diabetes Drug May Have Led To 500 Deaths
- Smith & Nephew Loses 2nd Bid To Kill FCA Dispute
- Siga Says Survey Will Bolster Bid For $2.8B Contract
- Wachtell Reps Cardinal Health In $1.3B Kinray Buy
- Upsher-Smith Faces False Marking Suit Over Diet Drug
- 2nd Circ. Remands State Claims In Pfizer Firing Suit
- Safe Life Settles Fight Over 3M Respirator Patents
- The Challenges Of FDA's Nascent Biosimilars Regime
- Ameritox To Pay $16M To Resolve Medicaid FCA Suit
- Rituxan Wrongful Death Suit Stays In Federal Court
- Greenberg Adds Veteran Senate Atty To Health Group
- Cancer Patients Lose Discovery Battle With Insurer
- Mobile Medical Loses Fight For Veterans Hospital Job
- $3M Bail Set For Doctor Accused Of Tipping Off Fund
- Stanford Appeal Reignites IP Custody Battle
- Ex-Baseball Player Gets 9 Years For Medicare Fraud
- FDA Accused Of Contempt In Plan B Availability Case
- Settlement Funds Established In Avandia MDL
- Stryker Can't Nix USPTO Ruling In Bone Screw IP Row
- 3 Things Accountable Care Organizations Can Do Now
- Lilly Chemotherapy Drug Patent Valid, Judge Rules
- Contractor, US Settle Over Clinic Construction Delays
- Insurer On Hook For Defense In BestComp E&O Suit
- Judge Clears Path For Generic Dr. Reddy's Asthma Drug
- CIBC Fights Fox Rothschild Fees In Chem Rx Ch. 11
- HHS Eases Restrictions On Grandfathered Plans
- Healthfirst Hands Over $7.7M In Marketing Rep OT Suit
- FDA Seeks To Improve Safety Of Heart Defibrillators
- State Lawmakers Back Health Care Reform
- Universal Health Agrees To Divest For $3.1B PSI Deal
- Otsuka Triumphs In Abilify Patent Litigation
- Pay-For-Delay Is Smart And Legal, Drugmakers Argue
- Hospira Sues Caraco To Block Generic Precedex
- SG To Participate In Cigna High Court Pension Fight
- Flonase Purchasers Win Class Cert. In Suit Against GSK
- M&A Risks To Your 'Grandfathered' Health Plan
- Medicare Fraud Units Will Scrutinize Health Care Cos.
- Foxhollow Loses Bid To Toss Merger Breach Suit
- Doctor Preps Bail Package In Hedge Fund Tip-Off Case
- Utah Slaps GSK With Medicaid Fraud Suit Over Avandia
- Ecolab To Snatch Up OR Solutions For $260M
- Economists Back Obama On Health Care Reform
- BASF Dodges Claims From Vitamin Cartel Victims
- Smith & Nephew Asks Court To Rethink FCA Ruling
- Brazil Probes Alleged Ambulance Bid-Rigging Scheme
- US Reversal Frames Issues In Myriad's Appeal
- FDA Releases Raw Heparin Shipments To Amphastar
- Changes In Doctor Payments Under EHR Incentive
- Convicted Pharma Fraudster Seeks Post-Trial Acquittal
- Teva, Others Settle With Counties In Medicaid MDL
- Hawaii Sues McKesson For Allegedly Inflating AWPs
- AstraZeneca Hits Watson With Crestor Patent Suit
- Pfizer Fights Whistleblower Retaliation Suit In 2nd Circ.
- Fed. Circ. Revives Merck Suit Over Temodar Patent
- Cobalt's Generic Boniva Barred In Roche IP Spat
- Mylan Reaches $2.6M Deal In Mass. Medicaid Case
- GOP Senate Leader Backs Suit Over Health Care Reform
- Fed. Circ. Nixes Abraxis Win In Naropin Patent Row
- Feds Hit Back At Stryker Biotech's Dismissal Bids
- Fla. Man Says Philip Morris Should Fund Lung Tests
- Prevention Beats Cure For Medicare Enrollment
- DC Circ. Upholds Exclusivity For ADHD Drug Vyvanse
- Md. Hospital To Pay $22M To Settle Kickback Claims
- Abbott, Others Argue For New Inequitable Conduct Rule
- Omnicare Investors Drop High Court Appeal
- Ex-GSK Atty Indicted For Obstructing Federal Probe
- Class Action Alleges Dexatrim Contains Carcinogen
- FDA Warns Claris Over Contaminated Drugs
- FDA Got Too Close To Drug Firms: GAO
- House Leaders To Probe FDA's Puerto Rico Office
- Navy Defends Decision To Nix $15M Drug Test Deal
- FDA Blames GE, Toshiba Radiation Problems On Misuse
- Wyeth Effexor Patent Valid, Infringed: Australian Judge
- Novo Nordisk, Actavis End PrandiMet Patent Spat
- DOJ Ends Reagents Antitrust Probe Into Immucor
- Navigating CMS' New Self-Referral Disclosure Protocol
- AAI Urges FTC To Reconsider CVS Caremark Merger
- Edwards Lifesciences Subpoenaed Over Heart Monitor
- Centocor Loses Bid To Dismiss Remicade Suit
- High Court Considers Tax Status Of Medical Residents
- Tulsa Medical Center Can't Escape Medicaid Suit
- Kaiser Health Inks $2.9M Settlement With IT Staff
- Judge Reinstates Opt-Ins In Pa. Hospital FLSA Action
- Inequitable Conduct Doctrine Takes Stage In Fed. Circ.
- Siga Appeals $2.8B Drug-Contract Disqualification
- Whistleblowers Seek To Revive Suit Against Medco
- Q&A With Dinsmore & Shohl's James Zeszutek
- High Court Won't Hear Calif. Group's Health Law Fight
- Weil Gotshal Advises Lilly In $800M Avid Deal
- 10 Appellate Tips From A Former Chief Justice
- Five Nabbed In Texas Over $10M Medicare Scheme
- Arnzen Molloy Can Stay On Harassment Indemnity Suit
- Ex-Bristol Myers Worker Pleads Guilty To IP Theft
- US, States Feud Over Health Care Reform
- Dendreon Inks $17M Deal In Shareholder Action
- FDA Falls Short On Medical Device Monitoring: Report
- Akzo, AstraZeneca Face 'Dead Peasant' Policy Suit
- State Farm Dodges Class Action Over Medicare
- Pharmacy's Provigil Action To Remain In Federal Court
- Astellas Targets Glenmark Over Eczema Drug
- Nanoparticles: A New Mass Tort Frontier
- Smith & Nephew Fails To Shake Whistleblower Suit
- Class Can't Kill Plaintiffs Atty's AWP Ban Appeal
- KV Securities Plaintiffs Fight Denial Of Bid To Amend
- The Government Stance On Generic Preemption
- Alleged $42M Construction Kickbacker Seeks Severance
- Valeant Settles Biovail Frivolous Suit Claims For $10M
- Judge Squashes Hostess Trans Fat Labeling Suit
- Allergan's Bid For New Trial Rejected In Zymar Case
- MDL Judge Wants More Info On Zicam Settlement
- Genzyme Sues Lupin Over Generic Welchol
- Election Leaves Fate Of Patent Reform Up In The Air
- Nationwide Settles Coverage Suit Over Corpse Sales
- Watson Reaches Deal With J&J For Concerta Generic
- 5th Circ. Revives Cardinal Health Qui Tam Suit
- Health Care Unions Actively Using New Tactics
- Fosamax Judge Restricts Bellwether Trial Evidence
- Ariz., Okla. Voters Reject Obama's Health Care Mandate
- Thermo Fisher Hit With Patent Suit Over Lab Device
- DOJ's Policy Shift Could Change Future Of DNA IP
- Chem Rx's $70M Sale To PharMerica Gets Green Light
- FDA Starts On Path To Approving Biosimilars
- French Doctor Busted For Allegedly Selling Inside Tips
- Mylan Drops Appeal In Generic Paxil Contract Fight
- CareFusion Antitrust Claims Nixed In Medtronic Suit
- Fed. Circ. Denies Lilly En Banc Review In Gemzar Feud
- FDA Issues Class I Recall Of Medtronic's Octopus Nuvo
- Fed. Circ. Upholds Injunction On Generic Pulmicort
- Skadden Reps McKesson In $2B US Oncology Deal
- Cancer Patients Fight Insurer's Bid To Block Discovery
- Supreme Court Disbars Former Fen-Phen Torts Atty
- Pfizer Recalls 38,000 More Bottles Of Lipitor
- Army Properly Rejected Medfinity X-Ray Bid: GAO
- Blue Cross Michigan Hit With 'Most Favored' Action
- Fresenius Goes After Lupin Over PhosLo ANDA
- DOJ Urges Compromise In Gene Patent Appeal Brief
- GAO Sustains Bid Protest Over VA Hospital Contract
- High Court To Weigh Rights In Gov't-Funded Inventions
- Increasing Scrutiny Of Gov't Contingent Fee Deals